Description of blood Analysis: 

C-Peptide is a short chain of amino acids produced by the pancreas as a byproduct of insulin synthesis. Proinsulin is cleaved into two parts: one molecule of insulin and one molecule of C-peptide. Because they are produced in equal amounts (equimolar), C-peptide serves as a highly accurate mirror of the body’s natural insulin production. Unlike insulin, which is quickly cleared by the liver, C-peptide remains in the bloodstream longer and is cleared by the kidneys, making it a more stable marker for laboratory measurement.

What Does the Test Represent?

• Goal: To determine how much natural insulin the pancreas is currently secreting.
• Main Application: Distinguishing between Type 1 and Type 2 diabetes, investigating the cause of hypoglycemia, and evaluating pancreatic function after surgery or in the presence of tumors.
• Method: Chemiluminescent immunoassay (CLIA).

Collection Recommendations (General)

• Timing: Usually performed fasting, early in the morning. In some cases, a “stimulated” test is performed after a meal or a glucagon injection to see how the pancreas responds to a challenge.
• Hygiene: Standard venipuncture procedure.
• Material: Venous blood (serum).
• Specific Rules: Fasting for 8–12 hours is generally required to establish a baseline.

What Can Affect the Results?

• Factors Altering Levels: Kidney dysfunction (which can cause C-peptide to build up in the blood, leading to falsely high results), obesity, and high blood pressure.
• Medications: While C-peptide is not affected by injected (exogenous) insulin, drugs that stimulate the pancreas to produce more insulin (like sulfonylureas) will increase C-peptide levels.

When to Take the Test?

• Recommendations: If you have a new diagnosis of diabetes and the type is unclear, or if you experience symptoms of low blood sugar (hypoglycemia) to check if your body is overproducing insulin. It is also used to monitor the “honeymoon phase” in newly diagnosed Type 1 diabetics.
• Preparation: Fasting is mandatory. Water is allowed, but avoid all other beverages and food until the blood is drawn.

How to Interpret the Results? 

The interpretation of C-Peptide levels is strictly a clinical analytical task for a physician. Low levels of C-peptide (and insulin) suggest that the pancreas is producing little to no insulin, which is characteristic of Type 1 Diabetes. High levels of C-peptide may indicate Type 2 Diabetes (insulin resistance) or an insulin-secreting tumor (insulinoma). Only a specialist can “fine-tune” the diagnosis by looking at C-peptide in direct relation to the patient’s simultaneous blood glucose level.

Possible Further Investigations

• Glucose (Fasting): To evaluate C-peptide levels in the context of current blood sugar.
• Insulin Ab (Antibodies): To help confirm an autoimmune cause of diabetes.
• HbA1c: To assess long-term glycemic control.
• Glucagon Stimulation Test: To measure the maximum secretory capacity of the pancreas.

When Does the Next Step Make Sense? 

If C-peptide levels are found to be very low, the next step is often the immediate initiation or adjustment of insulin therapy. If they are high, the focus shifts to improving insulin sensitivity or searching for pancreatic abnormalities. Understanding your C-peptide level is the key to choosing the correct treatment path for metabolic health.

👉 If necessary, you can discuss the analysis results with a specialist such as an endocrinologist (Doctors – TAMC)